ImmuCell ROA 2012-2025 | ICCC
Current and historical return on assets (ROA) values for ImmuCell (ICCC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ImmuCell ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.00B | $0.05B | 6.52% |
| 2025-06-30 | $0.00B | $0.05B | 4.40% |
| 2025-03-31 | $0.00B | $0.05B | -2.26% |
| 2024-12-31 | $0.00B | $0.05B | -4.60% |
| 2024-09-30 | $0.00B | $0.04B | -9.25% |
| 2024-06-30 | $0.00B | $0.04B | -9.20% |
| 2024-03-31 | $0.00B | $0.04B | -6.82% |
| 2023-12-31 | $-0.01B | $0.04B | -11.36% |
| 2023-09-30 | $-0.01B | $0.05B | -13.56% |
| 2023-06-30 | $-0.01B | $0.04B | -13.48% |
| 2023-03-31 | $-0.01B | $0.04B | -13.33% |
| 2022-12-31 | $0.00B | $0.05B | -6.52% |
| 2022-09-30 | $0.00B | $0.05B | -2.19% |
| 2022-06-30 | $0.00B | $0.05B | 0.00% |
| 2022-03-31 | $0.00B | $0.05B | 2.23% |
| 2021-12-31 | $0.00B | $0.04B | 0.00% |
| 2021-09-30 | $0.00B | $0.04B | 0.00% |
| 2021-06-30 | $0.00B | $0.04B | 0.00% |
| 2021-03-31 | $0.00B | $0.04B | -2.48% |
| 2020-12-31 | $0.00B | $0.04B | -2.48% |
| 2020-09-30 | $0.00B | $0.04B | -2.50% |
| 2020-06-30 | $0.00B | $0.04B | -5.03% |
| 2020-03-31 | $0.00B | $0.04B | -5.10% |
| 2019-12-31 | $0.00B | $0.04B | -5.10% |
| 2019-09-30 | $0.00B | $0.04B | -7.95% |
| 2019-06-30 | $0.00B | $0.04B | -5.52% |
| 2019-03-31 | $0.00B | $0.04B | -5.76% |
| 2018-12-31 | $0.00B | $0.03B | -6.02% |
| 2018-09-30 | $0.00B | $0.03B | -2.99% |
| 2018-06-30 | $0.00B | $0.03B | -3.05% |
| 2018-03-31 | $0.00B | $0.03B | 0.00% |
| 2017-12-31 | $0.00B | $0.03B | 3.42% |
| 2017-09-30 | $0.00B | $0.03B | 3.70% |
| 2017-06-30 | $0.00B | $0.03B | 4.04% |
| 2017-03-31 | $0.00B | $0.03B | 4.35% |
| 2016-12-31 | $0.00B | $0.03B | 0.00% |
| 2016-09-30 | $0.00B | $0.02B | 0.00% |
| 2016-06-30 | $0.00B | $0.02B | 0.00% |
| 2016-03-31 | $0.00B | $0.02B | 0.00% |
| 2015-12-31 | $0.00B | $0.02B | 0.00% |
| 2015-09-30 | $0.00B | $0.01B | 0.00% |
| 2015-06-30 | $0.00B | $0.01B | 0.00% |
| 2015-03-31 | $0.00B | $0.01B | 0.00% |
| 2014-12-31 | $0.00B | $0.01B | 0.00% |
| 2014-09-30 | $0.00B | $0.01B | 0.00% |
| 2014-06-30 | $0.00B | $0.01B | 0.00% |
| 2014-03-31 | $0.00B | $0.01B | 0.00% |
| 2013-12-31 | $0.00B | $0.01B | 0.00% |
| 2013-09-30 | $0.00B | $0.01B | 0.00% |
| 2013-06-30 | $0.00B | $0.01B | 0.00% |
| 2013-03-31 | $0.00B | $0.01B | 0.00% |
| 2012-12-31 | $0.00B | $0.01B | 0.00% |
| 2012-09-30 | $0.00B | $0.01B | 0.00% |
| 2012-06-30 | $0.00B | $0.01B | 0.00% |
| 2012-03-31 | $0.00B | $0.01B | 0.00% |
| 2011-12-31 | $0.00B | $0.01B | 0.00% |
| 2011-09-30 | $0.00B | $0.01B | 0.00% |
| 2011-06-30 | $0.00B | $0.01B | 0.00% |
| 2011-03-31 | $0.00B | $0.01B | 0.00% |
| 2010-12-31 | $0.00B | $0.01B | 0.00% |
| 2010-09-30 | $0.00B | $0.01B | 0.00% |
| 2010-06-30 | $0.00B | $0.01B | 0.00% |
| 2010-03-31 | $0.00B | $0.01B | 0.00% |
| 2009-12-31 | $0.00B | $0.01B | 0.00% |
| 2009-09-30 | $0.00B | $0.01B | 0.00% |
| 2009-06-30 | $0.00B | $0.01B | 0.00% |
| 2009-03-31 | $0.00B | $0.01B | 0.00% |
| 2008-12-31 | $0.00B | $0.01B | 0.00% |
| 2008-09-30 | $0.00B | $0.01B | 0.00% |
| 2008-06-30 | $0.00B | $0.01B | 0.00% |
| 2008-03-31 | $0.00B | $0.01B | 0.00% |
| 2007-12-31 | $0.00B | $0.01B | 0.00% |
| 2007-09-30 | $0.00B | $0.01B | 0.00% |
| 2007-06-30 | $0.00B | $0.01B | 0.00% |
| 2007-03-31 | $0.00B | $0.01B | 0.00% |
| 2006-12-31 | $0.00B | $0.00B | 0.00% |
| 2006-09-30 | $0.00B | $0.00B | 0.00% |
| 2006-06-30 | $0.00B | $0.01B | 0.00% |
| 2006-03-31 | $0.00B | $0.01B | 0.00% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| 2005-09-30 | $0.00B | $0.01B | 0.00% |
| 2005-06-30 | $0.00B | $0.01B | 0.00% |
| 2005-03-31 | $0.00B | $0.01B | 0.00% |
| 2004-12-31 | $0.00B | $0.01B | 0.00% |
| 2004-09-30 | $0.00B | $0.01B | 0.00% |
| 2004-06-30 | $0.00B | $0.01B | 0.00% |
| 2004-03-31 | $0.00B | $0.01B | 0.00% |
| 2003-12-31 | $0.00B | $0.01B | 12.50% |
| 2003-09-30 | $0.00B | $0.01B | 25.00% |
| 2003-06-30 | $0.00B | $0.01B | 25.81% |
| 2003-03-31 | $0.00B | $0.01B | 26.67% |
| 2002-12-31 | $0.00B | $0.01B | 13.79% |
| 2002-09-30 | $0.00B | $0.01B | 0.00% |
| 2002-06-30 | $0.00B | $0.01B | 0.00% |
| 2002-03-31 | $0.00B | $0.01B | 0.00% |
| 2001-12-31 | $0.00B | $0.01B | 0.00% |
| 2001-09-30 | $0.00B | $0.01B | 29.63% |
| 2001-06-30 | $0.00B | $0.01B | 33.33% |
| 2001-03-31 | $0.00B | $0.01B | 38.10% |
| 2000-12-31 | $0.00B | $0.01B | 44.44% |
| 2000-09-30 | $0.00B | $0.00B | 0.00% |
| 2000-06-30 | $0.00B | $0.00B | 0.00% |
| 2000-03-31 | $0.00B | $0.00B | 0.00% |
| 1999-12-31 | $0.00B | $0.00B | 0.00% |
| 1999-09-30 | $0.00B | $0.00B | 0.00% |
| 1999-06-30 | $0.00B | $0.00B | 0.00% |
| 1999-03-31 | $0.00B | $0.00B | 0.00% |
| 1998-12-31 | $0.00B | $0.00B | 0.00% |
| 1998-09-30 | $0.00B | $0.00B | 0.00% |
| 1998-06-30 | $0.00B | $0.00B | 0.00% |
| 1998-03-31 | $0.00B | $0.00B | 0.00% |
| 1997-12-31 | $0.00B | $0.00B | 0.00% |
| 1997-09-30 | $0.00B | $0.00B | 0.00% |
| 1997-06-30 | $0.00B | $0.00B | 0.00% |
| 1997-03-31 | $0.00B | $0.00B | 0.00% |
| 1996-12-31 | $0.00B | $0.00B | 0.00% |
| 1996-09-30 | $0.00B | $0.00B | 0.00% |
| 1996-06-30 | $0.00B | $0.00B | 0.00% |
| 1996-03-31 | $0.00B | $0.00B | 0.00% |
| 1995-12-31 | $0.00B | $0.00B | 0.00% |
| 1995-09-30 | $0.00B | $0.00B | 0.00% |
| 1995-06-30 | $0.00B | $0.00B | 0.00% |
| 1995-03-31 | $0.00B | $0.00B | 0.00% |
| 1994-12-31 | $0.00B | $0.00B | 0.00% |
| 1994-09-30 | $0.00B | $0.00B | 0.00% |
| 1994-06-30 | $0.00B | $0.00B | 0.00% |
| 1994-03-31 | $0.00B | $0.00B | 0.00% |
| 1993-12-31 | $0.00B | $0.00B | 0.00% |
| 1993-09-30 | $0.00B | $0.00B | 0.00% |
| 1993-06-30 | $0.00B | $0.00B | 0.00% |
| 1993-03-31 | $0.00B | $0.00B | 0.00% |
| 1992-12-31 | $0.00B | $0.00B | 0.00% |
| 1992-09-30 | $0.00B | $0.00B | 0.00% |
| 1992-06-30 | $0.00B | $0.00B | 0.00% |
| 1992-03-31 | $0.00B | $0.00B | 0.00% |
| 1991-12-31 | $0.00B | $0.00B | 0.00% |
| 1991-09-30 | $0.00B | $0.00B | 0.00% |
| 1991-06-30 | $0.00B | $0.00B | 0.00% |
| 1991-03-31 | $0.00B | $0.00B | 0.00% |
| 1990-12-31 | $0.00B | $0.00B | 0.00% |
| 1990-09-30 | $0.00B | $0.00B | 0.00% |
| 1990-06-30 | $0.00B | $0.00B | 0.00% |
| 1990-03-31 | $0.00B | $0.00B | 0.00% |
| 1989-12-31 | $0.00B | $0.00B | 0.00% |
| 1989-09-30 | $0.00B | $0.00B | -22.22% |
| 1989-06-30 | $0.00B | $0.00B | -21.05% |
| 1989-03-31 | $0.00B | $0.01B | -19.05% |
| 1988-12-31 | $0.00B | $0.01B | -18.18% |
| 1988-06-30 | $0.00B | $0.01B | 0.00% |
| 1988-03-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.060B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |